Tags: health | care | sector | fit | drug | stock | prices

Health-Care Sector Looking Quite Fit

Health-Care Sector Looking Quite Fit
(Dollar Photo Club)

By Friday, 14 September 2018 11:30 AM Current | Bio | Archive

The S&P 500 Health Care sector might have started 2018 looking sickly, but it’s entering the homestretch as one of the top-performing sectors year to date.

Threats by the Trump administration to force drug price cuts have yet to materialize. Instead, a robust market for mergers and acquisitions along with IPOs have helped lift stock prices.

Here’s the year-to-date (ytd) performance derby for the S&P 500 sectors through Tuesday’s close: Consumer Discretionary (18.3%), Information Technology (17.8), Health Care (11.3), S&P 500 (8.0), Industrials (2.3), Utilities (2.1), Real Estate (1.5), Energy (1.2), Financials (1.0), Materials (-2.2), Consumer Staples (-5.2), and Telecom Services (-5.7) (Fig. 1).

Driving the Health Care sector’s robust ytd performance are the following industries: S&P 500 Health Care Equipment stock price index (20.6%), Managed Health Care (16.6), Health Care Services (11.7), and Pharmaceuticals (8.7). Lagging behind is Biotechnology, up only 1.1% ytd (Fig. 2).

(1) Small but mighty. Even more impressive is the performance of small- and mid-cap Health Care stocks. The S&P 400 Health Care stock price index has risen 31.7% ytd, and the S&P 600 Health Care stock price index has soared 45.2% (Fig. 3). That makes Health Care the best performing of the 11 sectors in S&P’s small- and mid-cap indexes.

The industries driving the ytd performance of the S&P 400 and S&P 600 Health Care indexes include Managed Health Care (64.3%, 43.9%), Services (47.7, 23.4), Facilities (39.1, 18.2), Equipment (36.3, 48.1), Life Sciences (30.0, 41.8), Supplies (26.0, 40.4), Biotechnology (25.4, 39.8), Technology (14.8, 63.1), and Pharmaceuticals (-6.7, 43.0) (Fig. 4 and Fig. 5).

(2) Deals galore. Mergers and acquisitions have likely helped the performance of health care stocks. There have been $381.0 billion deals done in the global health care sector ytd, up from $240.1 billion over the same period in 2017, according to Dealogic data on wsj.com. That makes Health Care the second most active sector for M&A this year, trailing only the Tech sector.

Health Care companies also top the listing of the largest global M&A deals done ytd. Takeda Pharmaceutical announced in April plans to acquire Shire for $81.5 billion, making it the largest acquisition announced in 2018. Right behind it is Cigna’s pending acquisition of Express Scripts for $69.8 billion.

In addition, the IPO market has welcomed offerings from the Health Care sector. The sector has raised $15.0 billion in the global IPO markets this year compared to $10.7 billion raised at the same point in 2017. It’s the fourth most active S&P sector in IPOs this year, behind Tech, Finance, and Telecom.

(3) Digging down. Analysts are expecting the strong financial results from the S&P 500 Health Care sector to continue into next year. Revenue is forecast to climb by 6.1% this year and 5.2% in 2019, and earnings are forecast to improve by 14.6% and 8.1%, respectively (Fig. 6 and Fig. 7). The sector’s forward P/E, at 16.1, doesn’t appear stretched looking at its history over the past 25 years (Fig. 8).

As we mentioned above, the S&P 500 Health Care Equipment stock price index has been the best-performing industry within the sector. It’s expected to produce 12.5% earnings growth this year and 10.3% growth in 2019 (Fig. 9). However, its strength is no secret. The industry has a forward P/E of 22.5 (Fig. 10).

Three of the Health Care Equipment industry’s top-performing stocks are Idexx, Intuitive Surgical, and Boston Scientific. They each play into three strong trends driving the sector: pets, robots, and M&A. Idexx provides testing and other services to veterinarians and research facilities, among other things. Its stock has rallied 55.0% ytd, making it the industry’s top performer. Not far behind with a 49.7% ytd return is Intuitive Surgical, which makes the da Vinci robotic surgery platform. And Boston Scientific has rallied 45.8% ytd, after announcing a number of smaller acquisitions to bolster its growth.

Dr. Ed Yardeni is the President of Yardeni Research, Inc., a provider of independent global investment strategy research.
 

© 2021 Newsmax Finance. All rights reserved.


EdwardYardeni
The S&P 500 Health Care sector might have started 2018 looking sickly, but it’s entering the homestretch as one of the top-performing sectors.
health, care, sector, fit, drug, stock, prices
677
2018-30-14
Friday, 14 September 2018 11:30 AM
Newsmax Media, Inc.
 
Newsmax TV Live
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved